Source: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-cand-4_03-cv-01431/USCOURTS-cand-4_03-cv-01431-28/pdf.json

Nature of Suit Code: 830
Nature of Suit: Patent
Cause of Action: 35:271 Patent Infringement

---

United States District Court

For the Northern District of California

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

United States District Court

For the Northern District of California

IN THE UNITED STATES DISTRICT COURT

FOR THE NORTHERN DISTRICT OF CALIFORNIA

FRESENIUS MEDICAL CARE

HOLDINGS, INC., et al.,

Plaintiffs,

 v.

BAXTER INTERNATIONAL, INC., et al.,

Defendants. _______________________________________

No. C 03-1431 SBA

 

ORDER

[Docket Nos. 677, 686, 688]

For the reasons set forth by the Court on the record at the June 13, 2006 Pretrial Conference in

the above-captioned matter, 

IT IS HEREBY ORDERED as follows:

(1) Fresenius' Motion in Limine to Exclude Evidence and Argument Regarding

Summary Judgment Orders [Docket No. 688] is GRANTED IN PART;

(2) Fresenius' Motion in Limine Regarding FDA Approval of the Sarns 9000

[Docket No. 686] is GRANTED IN PART AND DENIED IN PART; and

(3) Baxter's Motion in Limine Precluding Argument and Evidence Regarding

Different PTO Proceedings [Docket No. 677] is TENTATIVELY GRANTED.

Upon motion by either party, the Court will reconsider whether the August 2003

Board Opinion and the June 2005 Office Action shall be admitted or excluded

after Baxter has presented its rebuttal of Fresenius' invalidity arguments. 

IT IS SO ORDERED.

 Dated: 6/19/06 SAUNDRA BROWN ARMSTRONG

United States District Judge

Case 4:03-cv-01431-PJH Document 779 Filed 06/19/06 Page 1 of 2
United States District Court

For the Northern District of California

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

2

Case 4:03-cv-01431-PJH Document 779 Filed 06/19/06 Page 2 of 2